Richiedi una copia del documento: Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent : 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials

Captcha code
Annulla